Inventor · disambiguated record
Bernard Krust
Also filed as: KRUST BERNARD
18 granted patents·2 pending applications·183 citations·filing 1989–2009
95Inventor score
Top patents by PatentIndex Score
20 records- 0185US6440657B1Nucleic acids and peptides of human immunodeficiency virus type (HIV-1)PASTEUR INSTITUT·Filed 2000·Granted Aug 27, 2002·9 cites·6 claims
- 0284US6984721B2Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins GP300, P200, and P90/80PASTEUR INSTITUT·Filed 2000·Granted Jan 10, 2006·11 cites·18 claims
- 0383US5208321AHIV-2 transmembrane glycoprotein homodimer (GP 80)PASTEUR INSTITUT·Filed 1989·Granted May 4, 1993·21 cites·10 claims
- 0480US7507417B2Immunogenic compositions comprising human immunodeficiency virus type 2 (HIV-2) glycosylated and unglycosylated envelope proteins and their methods of preparationPASTEUR INSTITUT·Filed 2005·Granted Mar 24, 2009·4 cites·3 claims
- 0577US8173767B2Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIVHOVANESSIAN ARA·Filed 2008·Granted May 8, 2012·2 cites·10 claims
- 0672US7364744B2Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIVPASTEUR INSTITUT·Filed 2004·Granted Apr 29, 2008·6 cites·8 claims
- 0769US6608179B1Antibodies, that bind to HIV-2 transmembrane glycoprotein homodimer (gp 80)PASTEUR INSTITUT·Filed 1999·Granted Aug 19, 2003·14 cites·6 claims
- 0868US5843638ANucleic acids and pepties of human immunodeficiency virus type-1 (HIV-1).PASTEUR INSTITUT·Filed 1995·Granted Dec 1, 1998·15 cites·1 claims
- 0966US6261571B1Immunogenic compositions comprising dimeric forms of the human immunodeficiency virus type 2 (HIV-2) and simian immunodeficiency virus (SIV) envelope glycoproteinsPASTEUR INSTITUT·Filed 1994·Granted Jul 17, 2001·16 cites·8 claims
- 1063US6197496B1Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins gp300, p200, and p90/80PASTEUR INSTITUT·Filed 1994·Granted Mar 6, 2001·14 cites·19 claims
- 1162US2004010125A1HIV-2 transmembrane glycoprotein homodimer (gp 80)PASTEUR INSTITUT·Filed 2003·Application pending·0 cites
- 1261US5312902ADimer of the precursor of HIV-2 envelope glycoproteinPASTEUR INSTITUT·Filed 1991·Granted May 17, 1994·18 cites·6 claims
- 1358US5807992AHIV-2 transmembrane glycoprotein homodimer (gp 80)PASTEUR INSTITUT·Filed 1995·Granted Sep 15, 1998·9 cites·2 claims
- 1456US5610035AMethods for the preparation of hybridomas producing lymphadenopathy-associated virus (LAV) GP110-specific monoclonal antibodies and methods for the purification of GP110 employing said monoclonal antibodiesPASTEUR INSTITUT·Filed 1994·Granted Mar 11, 1997·13 cites·3 claims
- 1554US5550052AHybrid cell line formed between T4 lymphocytes and tumoral lymphoid type cellsPASTEUR INSTITUT·Filed 1992·Granted Aug 27, 1996·11 cites·5 claims
- 1653US5470702AHIV-2 transmembrane glycoprotein homodimer (gp 80)PASTEUR INSTITUT·Filed 1993·Granted Nov 28, 1995·8 cites·3 claims
- 1752US8790898B2Synthetic peptides corresponding to overlapping neutralizing determinants in the CBD1 epitope induce broadly neutralizing antibodiesHOVANESSIAN ARA·Filed 2009·Granted Jul 29, 2014·0 cites·12 claims
- 1847US6056963AImmunogenic compositions comprising glycosylated and deglycosylated monomeric and dimeric forms of HIV-2 enveloped glycoproteinsPASTEUR INSTITUT·Filed 1995·Granted May 2, 2000·7 cites·4 claims
- 1943US5407811AMonoclonal antibodies to GP110 of HIV and hybridomas secreting these antibodiesPASTEUR INSTITUT·Filed 1992·Granted Apr 18, 1995·5 cites·2 claims
- 2043US2002076693A1Novel cell surface receptor for HIV retroviruses, therapeutic and diagnostic usesINST PASTEUR AND CT NAT DE LA·Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bernard Krust files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →